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Abstract
Recent studies have focused on the use of multi-nutrient dietary interventions in search of alternatives for the treatment
and prevention of Alzheimer’s disease (AD). In this study we investigated to which extent long-term consumption of two
specific multi-nutrient diets can modulate AD-related etiopathogenic mechanisms and behavior in 11-12-month-old
AbPPswe-PS1dE9 mice. Starting from 2 months of age, male AbPP-PS1 mice and wild-type littermates were fed either a
control diet, the DHA+EPA+UMP (DEU) diet enriched with uridine monophosphate (UMP) and the omega-3 fatty acids
docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), or the FortasynH Connect (FC) diet enriched with the DEU
diet plus phospholipids, choline, folic acid, vitamins and antioxidants. We performed behavioral testing, proton magnetic
resonance spectroscopy, immunohistochemistry, biochemical analyses and quantitative real-time PCR to gain a better
understanding of the potential mechanisms by which these multi-nutrient diets exert protective properties against AD. Our
results show that both diets were equally effective in changing brain fatty acid and cholesterol profiles. However, the diets
differentially affected AD-related pathologies and behavioral measures, suggesting that the effectiveness of specific
nutrients may depend on the dietary context in which they are provided. The FC diet was more effective than the DEU diet
in counteracting neurodegenerative aspects of AD and enhancing processes involved in neuronal maintenance and repair.
Both diets elevated interleukin-1b mRNA levels in AbPP-PS1 and wild-type mice. The FC diet additionally restored
neurogenesis in AbPP-PS1 mice, decreased hippocampal levels of unbound choline-containing compounds in wild-type and
AbPP-PS1 animals, suggesting diminished membrane turnover, and decreased anxiety-related behavior in the open field
behavior. In conclusion, the current data indicate that specific multi-nutrient diets can influence AD-related etiopathogenic
processes. Intervention with the FC diet might be of interest for several other neurodegenerative and neurological
disorders.
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Introduction
Alzheimer’s disease (AD) is a complex neurodegenerative
disorder that affects over 36 million people worldwide. The exact
cause of AD is still largely unknown despite over 100 years of
extensive research, and still no curative treatments are available.
Aging is recognized as the main risk factor for the late-onset
sporadic form of AD (SAD), while early-onset familial AD (FAD)
has been linked to autosomal dominant mutations in the gene for
the amyloid-b precursor protein (AbPP) and the genes for the
presenilin 1 (PS1) and presenilin 2 (PS2) proteins [1,2]. Both SAD
and FAD share specific neuropathologic features, including
neurofibrillary tangles, amyloid-b (Ab) plaques, neuronal loss,
white matter lesions and synaptic changes in vulnerable brain
regions such as the hippocampus and neocortex [3,4]. For
decades, the production and accumulation of the Ab peptide has
been proposed to be the primary trigger of the pathological
cascade leading to neurodegeneration and the development of AD.
Besides Ab, several other (risk) factors have been proposed to play
an important role in the development of AD.
Many large epidemiological studies have demonstrated that
vascular disorders, such as hypercholesterolemia and atheroscle-
rosis, are important risk factors for AD [5–7]. Furthermore,
cardiovascular disease risk factors, such as a sedentary lifestyle,
high saturated fatty acid (SFA) intake, diabetes, smoking and
obesity, are associated with a higher risk of developing AD and
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other dementias [8–11]. Many of these cardiovascular risk factors
are modifiable. Modifying cardiovascular risk factors, for example
by changing lifestyle, might ultimately also affect the risk of
developing AD.
Due to the limited and short-lasting efficacy of the current drugs
available [12], recent work has focused on the use of dietary
interventions for the treatment and prevention of AD. Omega-3
long-chain poly-unsaturated fatty acids (n3 lc-PUFAs), such as
docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA),
have shown protective properties with regard to risk of age-related
cognitive decline and AD [13–16]. The mechanisms by which
these dietary nutrients exert protective properties against AD are
still under investigation, but several lines of evidence have shown
beneficial effects of n3 lc-PUFAs on the cardiovascular system
[17,18] and on neuronal membrane properties [19,20]. These
beneficial effects on the cardiovascular system have been explained
by the capacity to decrease blood pressure [21], lower plasma
triacylglycerols [22,23], prevent arrhythmias [24], improve vas-
cular reactivity [25,26], decrease atherosclerosis [27], and suppress
inflammatory processes [28]. Furthermore, high levels of n3 lc-
PUFAs replace omega-6 fatty acids (n6 FAs) and cholesterol from
cell membranes, leading to increased membrane fluidity, increased
number of receptors, enhanced receptor binding and affinity,
better ion channel functionality, and modulation of gene
expression of many enzyme proteins involved in signal transduc-
tion processes [29–31]. As a result, this will lead to improved
neurotransmission and signaling [32], which is important for
optimal cognitive functioning [33]. Other dietary components, like
B vitamins and antioxidants, have also been shown to protect the
brain from oxidative and inflammatory damage [34–36], and
synaptic and neuronal loss [37,38]. However, when tested in a
clinical setting supplementation with single nutrients is marginally
effective in improving disease status [39–42]. It has been suggested
that approaches with multiple nutritional components might be
more promising, since not individual nutrients but dietary patterns
were identified as a factor influencing the risk of developing AD
[43].
Combined administration of different nutrients has shown
increased effectiveness in altering specific parameters involved in
AD. Supplementation with DHA or uridine monophosphate
(UMP) improved water maze performance of environmentally
impoverished rats. However, the combined administration of
DHA and UMP was more effective in improving learning abilities
[44]. Furthermore, performance on the four-arm radial maze, T-
maze and Y-maze tests by normal adult gerbils was improved by
supplementation of DHA and choline, and was even further
enhanced by coadministering UMP [45]. In addition to enhancing
cognitive performance, combinations of nutrients were shown to
be more effective than single nutrients in counteracting neurode-
generative aspects of AD [38,46,47] and enhancing processes
involved in neuronal regeneration and function [48–50]. More-
over, clinical trials with combinations of nutrients have shown
beneficial effects on memory performance in patients with mild
AD [51–53].
In the current study, we wanted to investigate the extent to
which long-term consumption of two specific multi-nutrients diets
can modulate behavior, cognition, hippocampal metabolite levels,
neurogenesis and inflammation in 11-12-month-old AbPP-PS1
mice. Starting from 2 months of age, animals were fed either a
control diet, a multi-nutrient diet enriched with DHA, EPA and
UMP (DEU), or a multi-nutrient diet enriched with DHA, EPA,
UMP, phospholipids, choline, folic acid, vitamins B6, B12, C,E
and selenium (FortasynH Connect). We performed behavioral
testing, proton magnetic resonance spectroscopy (1H MRS),
immunohistochemistry, biochemical analyses and quantitative
real-time PCR to gain a better understanding of the potential
mechanisms by which these multi-nutrient diets may exert
protective properties against AD.
Animals, Materials and Methods
Ethics statement, animals and housing conditions
The experiments were performed according to Dutch federal
regulations for animal protection and were approved by the
Veterinary Authority of the Radboud University Nijmegen
Medical Centre (Permit Number: RU-DEC 2008-126h). All
efforts were made to minimize suffering of the animals.
The AbPPswe-PS1dE9 founders were originally obtained from
Johns Hopkins University, Baltimore, MD, USA (D. Borchelt and
J. Jankowsky, Dept. of Pathology) and a colony was established at
the Radboud University Nijmegen Medical Centre, The Nether-
lands. In short, mice were created by co-injection of chimeric
mouse/human AbPPswe (mouse AbPP695 harboring a human Ab
domain and mutations K595N and M596L linked to Swedish
familial AD pedigrees) and human PS1dE9 (deletion of exon 9)
vectors controlled by independent mouse prion protein promoter
elements. The two transfected genes co-integrate and co-segregate
as a single locus [54,55]. This line (line 85) was originally
maintained on a hybrid background by backcrossing to C3HeJ6
C57BL6/J F1 mice (so-called pseudo F2 stage). For the present
work, the breeder mice were backcrossed to C57BL6/J for 13
generations to obtain mice for the current study. Throughout the
experiment, animals were housed in groups of 2–6 mice per cage
in a controlled environment, homogenously illuminated by normal
fluorescent room light at 60 lux, with room temperature at 21uC,
and an artificial 12:12 h light:dark cycle (lights on at 7 a.m.). Food
and water were available ad libitum.
Male transgenic AbPP-PS1 mice and their wild-type littermates
were fed either 1] a standard Control diet (CO diet), 2] a multi-
nutrient diet enriched with DHA, EPA and UMP (DEU diet), or
3] a multi-nutrient diet, called FortasynH Connect (FC diet),
containing precursors and cofactors in membrane synthesis and
maintenance via the Kennedy cycle [56], such as DHA, EPA,
UMP, phospholipids, choline, vitamins B6, B9, B12, C and E, folic
acid and selenium. The diets differed in composition with regard
to the fat blends used, as well as a number of supplemented
nutrients as indicated in Table 1. Diets were isocaloric and were
manufactured by Research Diet Services (Wijk bij Duurstede, The
Netherlands). In order to minimize oxidation of the n3 lc-PUFAs,
the experimental diets were stored at 220uC in 2-day supply
aliquots. Feeding the diets started when the mice reached the age
of 2 months and was maintained for the remainder of the
experiment. Animals underwent behavioral testing at 11 months of
age and subsequently MRI measurements at 12 months of age
(Figure 1). In total, 85 mice were used in the current study. Table 2
describes the number of mice used in each experimental group.
The body weight of the mice was determined one week before the
start of the behavioral tests at 11 months of age, and again on the
day of the MRI measurements at 12 months of age.
Behavioral analyses
Behavioral testing was performed in the following order
(Figure 1): First open field, followed by the Morris water maze
(MWM), and finally the reversal MWM (rMWM). All testing
sessions were performed during the light phase (between 9 a.m.
and 5 p.m.) and were recorded for computer-assisted analysis using
Ethovision XT 7.0 software (Noldus Information Technology
B.V., Wageningen, The Netherlands). All behavioral testing was
Diet Effect on AD Mice Brain Structure & Function
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performed in the same room, homogenously illuminated by
normal fluorescent room light at 60 lux.
Open field. To analyze explorative and anxiety-related
behavior, mice were placed individually in the center of a square
open field (50650640 cm) with white Plexiglas walls. Animals
were observed for 30 minutes, and the durations (seconds) of
walking, wall leaning, rearing, sitting and grooming were scored
and analyzed. These open field parameters were defined as
described previously [57,58]. In addition, total walking distance,
mean velocity, and the time spent in the corners and in the center
of the open field were obtained from the recorded sessions. The
center of the open field was defined as a square measuring
20620 cm, and the corners of the open field were defined as the
sum of all four 10610 cm squared corners.
Morris water maze (MWM). To investigate spatial learning
abilities, mice were tested in the Morris water maze (MWM). In
short, mice were placed in a pool (104 cm diameter) at different
starting positions and were trained to find a submerged platform
by using distant visual cues in the room. The water was made
opaque by the addition of milk powder, and was kept at a constant
temperature of 21-22uC. The maze was surrounded by white
curtains at a distance of 0.5 meter, which were marked by four
spatial cues varying in shape, size and color. The 8 cm diameter
round platform was submerged 1 cm below the water surface and
was placed in the middle of the northeast (NE) quadrant at a
distance of approximately 26 cm from the wall. The researcher
was always present at the same location in the room during all
trials (close to the southwest quadrant.
Acquisition (spatial learning): Mice were trained to find the
location of the submerged escape platform in 4 acquisition trials
per day (maximal swimming time 120 s; 30 s on the platform;
inter-trial interval 60 min) during 4 consecutive days. The latency
time (s) to find the hidden platform was scored. Starting positions
during the 4 trails/day were: south (S), north (N), east (E), west
(W). After each trial, mice were placed back in their home cage,
and a paper towel was available inside the cage for additional
drying.
Probe (spatial memory): All mice performed a single probe trial
60 min after the last trial on day 4. The platform was removed
from the swimming pool and mice were allowed to swim for 120 s.
The time spent swimming and searching in the NE quadrant
(former platform quadrant), the total swimming distance, the mean
velocity and the time spent swimming at the exact former platform
location were measured.
Reverse Morris water maze (rMWM). Four days after the
standard MWM probe trial, a simplified reversal MWM [58,59]
was performed in which the platform was relocated to a new
position in the southwest (SW) quadrant of the pool. In this
procedure, memory retrieval needs to be selective for the most
recently learned location, introducing an episodic like component
in the spatial memory task [60]. Acquisition and probe sessions
were performed similarly to the standard MWM sessions, except
that starting positions were E, W, S, and N, the target quadrant
was SW, and training lasted only 2 days (4 trials/day).
Magnetic resonance imaging (MRI)
MRI measurements were performed on a 11.7T BioSpec
Avance III small animal MR system (Bruker Biospin, Ettlingen,
Germany) equipped with an actively shielded gradient set of
600 mT/m. A circular polarized volume resonator was used for
signal transmission and an actively decoupled mouse brain
quadrature surface coil was used for signal detection (Bruker
BioSpin). During the experiments, mice were anesthetized with
3.5% isoflurane (Nicholas Primal (I) limited, London, United
Kingdom) for induction and 2% isoflurane for maintenance in a
mixture of N2O and oxygen (1:2) through a nose cone. The
anesthetic concentration was adjusted during the experiment in
order to maintain the breathing frequency at 70–100 per minute.
Respiration of the animal was monitored using a pneumatic
cushion respiratory monitoring system (Small Animal Instruments
Inc., NY, USA). Body temperature was measured using a rectal
thermometer and maintained at 37uC using a heated air flow
device. Mice were placed in a stereotactic holder in order to
immobilize the head and prevent unwanted movement during the
Figure 1. Time line of experimental design. At 2 months of age, AbPP-PS1 mice and their wild-type littermates were put on either a control diet
(CO), a DHA, EPA and UMP diet (DEU) or a FortasynH Connect diet (FC) for the remainder of the experiment. Behavioral testing was performed at 11
months of age. Animals were weight one week before starting the behavioral testing battery. In the first week of behavioral testing, animals were
exposed to the open field once for 30 minutes. In the second week, animals were trained in the Morris water maze (MWM) for 4 days. In the third
week, animals were trained in the reverse Morris water maze (rMWM) for 2 days. MR imaging was performed at 12 months of age. Mice were weighed
before MR scanning and sacrificed immediately after MR imaging.
doi:10.1371/journal.pone.0075393.g001
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scanning. Gradient echo (GE) images in the axial, sagittal and
coronal orientation were acquired to visualize the anatomy of the
mouse brain structures. Imaging parameters were: echo time
(TE) = 5 ms, repetition time (TR) = 630 ms, flip angle = 12 deg,
field of view (FOV) = 40640 mm, matrix size = 5126512, slice
thickness = 0.345 mm.
Magnetic resonance spectroscopy (MRS). Metabolite
concentrations in the hippocampus were determined using 1H
Table 1. Compositions of the experimental diets used, based on AIN-93M [172] with minor revisions.
Dietary groups
Source Control (CO) DHA, EPA, UMP (DEU) FortasynH Connect (FC)
g/100 g of diet g/100 g of diet g/100 g of diet
Corn Starch 35.57 34.57 33.12
Casein (.85% protein) 14.00 14.00 14.00
Corn dextrin 15.50 15.50 15.50
Sucrose 10.00 10.00 10.00
Dextrose 10.00 10.00 10.00
Fibers 5.00 5.00 5.00
Mineral mix (AIN-93M-MX) 3.50 3.50 3.50
Vitamin mix (AIN-93-VX) 1.00 1.00 1.00
Fats
Soy oil 1.900 – –
Coconut oil 0.900 0.100 0.100
Corn oil 2.200 1.870 1.870
Fish oil – 3.030 3.030
Additions
L-cysteine 0.180 0.180 0.180
Choline bitartrate (41.1% choline) 0.250 0.250 0.250
Tert-butylhydroquinone 0.0008 0.0008 0.0008
Pyridoxine-HCl – – 0.00328
Folic acid (90%) – – 0.00067
Cyanocobalamin (0.1% in mannitol) – – 0.00350
Ascorbic acid (100% pure) – – 0.160
dl-a-tocopheryl acetate (500 IU/g) – – 0.4650
UMP disodium (24% H2O) – 1.0 1.0
Choline chloride (74.576%) – – 0.402
Soy lecithin – – 0.402
Sodium selenite (46% min) – – 0.00023
Energy (kcal/100 g chow) 376.9 372.9 367.1
All diets were isoenergetic, contained 5% fat and standard vitamin and mineral premix, providing recommended daily amounts of these nutrients.
DHA=docosahexaenoic acid; EPA = eicosapentaenoic acid; UMP=uridine monophosphate.
doi:10.1371/journal.pone.0075393.t001
Table 2. Overview of the number of mice used in each experimental group.
Genotype Diet Total OF (r)MWM MRS IHC BCH
Wild-type CO 20 20 20 13–15 15 9
DEU 17 17 17 13–15 8 8
FC 16 16 16 14–15 16 7
AbPP-PS1 CO 14 14 13 10 5–7 5
DEU 8 8 8 7 4–5 3
FC 10 10 10 7 4–6 4
CO=Control diet; DEU = DHA, EPA, UMP diet; FC = FortasynH Connect diet; OF = open field; (r)MWM= (reverse) Morris water maze; MRS =magnetic resonance
spectroscopy; IHC= immunohistochemistry; BCH=biochemistry.
doi:10.1371/journal.pone.0075393.t002
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MRS with single voxel technique. The spectroscopic volume of
interest (VOI) of 1.061.062.0 mm was positioned unilaterally in
the right hippocampus based on the acquired anatomical images.
Water-suppressed 1H-MRS spectra were acquired with a point-
resolved spectroscopy sequence (PRESS) with a short echo time
with imaging parameters: TE= 10.905 ms, TR=2500 ms,
T1= 6.31 ms, T2= 4.59 ms, and 800 signal averages. Total
acquisition time for 1H MRS was 27 min per animal.
Quantification of the metabolite concentration was performed
using a the Linear Combination (LC) model software package
(LCModelTM, S. Provencher, Oakville, Canada). The quantifica-
tion algorithm of LCModelTMapplies linear combinations of
model spectra to calculate the best fit of the experimental
spectrum. The model spectra (dataset of prior knowledge) were
calibrated to match the magnetic field strength, sequence type and
sequence parameters used for data acquisition.
The criteria to select reliable metabolite tissue concentrations
were based on the Crame´r-Rao lower bounds (CRLB), which are
estimates of the S.D. of the fit for each metabolite [61] as
determined by LCModelTM. Only CRLB#20% were included in
the analysis. Concentrations with CRLB.20% were classified as
not detected. Six metabolites fulfilled the criteria: choline +
glycerophosphocholine + phosphocholine (tCho; choline-contain-
ing compounds), creatine + phosphocreatine (tCre), glutamine +
glutamate (Glx), myo-Inositol + glycine (mI+Gly), N-acetylaspartate
+ N-acetylaspartylglutamate (tNAA) and taurine (Tau). Although
the exact functions of these metabolites are not fully known, tNAA
is considered to be a marker of neuronal viability, tCre is involved
in energy metabolism, mI is a putative marker for microglia and
astrogliosis, and tCho is required for the synthesis of the
neurotransmitter acetylcholine, and of phosphatidylcholine, a
major constituent of membranes, and is therefore associated with
membrane turnover [62].
Tissue sampling
Directly following the MR measurements at 12 months of age,
half of the number of mice was sacrificed by cervical dislocation to
collect blood samples and brain tissue for biochemical analyses,
and the other half was sacrificed by transcardial perfusion fixation
with 4% paraformaldehyde (4% paraformaldehyde in 0.1 M
phosphate buffered saline (PBS; pH=7.3) to collect brains for
immunohistochemical stainings. Blood samples were collected via
eye extraction, and subsequently processed to obtain blood serum.
Blood serum was stored at -80uC, before further biochemical
processing. Non-perfused brains were snap frozen in liquid
nitrogen and then stored at 280uC, before further biochemical
processing. Perfused brains were collected and postfixed for 15 h
at 4uC in 4% paraformaldehyde fixative and subsequently stored
in 0.1 M PBS with 0.01% sodium azide at 4uC before further
immunohistochemical processing.
Immunohistochemistry
Before cutting, the brain tissue was cryoprotected by immersion
in 30% sucrose in 0.1 M PBS. Six series of 40 mm coronal sections
were cut through the brain using a sliding microtome (Microm
HM 440 E, Walldorf, Germany) equipped with an object table for
freeze sectioning at 260uC.
Immunohistochemistry was performed using standard free-
floating labeling procedures, and was carried out on a shaker table
at room temperature.
Doublecortin staining. Immature neurons were visualized
with anti-doublecortin antibody (polyclonal goat anti-doublecortin
(C18): sc-8066, Santa Cruz Biotechnology, Inc., Santa Cruz, CA,
USA) using one complete subseries of brain sections per animal
with 240 mm distance between the sections. Doublecortin is a
microtubule-associated protein that is exclusively found in somata
and processes of migrating and differentiating neurons [63,64]. In
short, after blocking the brain sections against endogenous
peroxidase with 0.3% H2O2 in 0.1 M PBS for 30 minutes, the
sections were pre-incubated with PBS-BT (0.1 M PBS with 0.1%
Bovine Serum Albumin and 0.3% Triton-X-100) for 30 minutes.
Brain sections were incubated overnight with polyclonal goat anti-
doublecortin (1:3000 diluted in PBS-BT) as primary antibody.
After incubating for 90 minutes with donkey anti-goat biotin
secondary antibody (1:1500 diluted in PBS-BT, Jackson Immu-
noResearch, West Grove, PA, USA), sections were transferred to a
solution containing Vector ABC-elite (1:800 in PBS-BT; Vector
Laboratories, Burlingame, CA, USA) for another 90 minutes.
Visualization of doublecortin-positive cells was achieved by
incubation with 0.02% 3-39diaminobenzidin tetra hydrochloride
with 0.3% ammonium nickel sulphate as an intensifier in 0.05 M
Tris buffer (DAB-Ni solution, pH=7.6) with 0.006% H2O2 for
10 min. After washing with 0.1 M PBS, all stained sections were
mounted on gelatin-coated slides (0.5% gelatin and 0.05%
chrome-alum), dried overnight in a stove at 37uC, dehydrated in
alcohol series, cleared with xylol and mounted in Entellan.
Quantification. Quantification of the doublecortin-positive
newly formed immature neurons in the subgranular zone of the
hippocampus was performed using a Zeiss Axioskop microscope
equipped with hardware and software from Microbrightfield
(Williston, VT, USA). Appropriate sections were digitized using a
computer-assisted analysis system (Stereo Investigator). Three
sections per animals were used at 2.70, 22.18 and 22.46
posterior to bregma, based on the mouse brain atlas of Franklin
and Paxinos [65]. Contours were drawn along the borders of the
hippocampus at 2.56 magnification and doublecortin-positive
(Dcx+) cells were counted at 206 magnification. All quantifica-
tions were performed by two independent raters who were blind to
the experiment groups. Measurements were averaged to obtain a
single value per animal.
Biochemical analyses
Serum and brain sterol analysis. Serum cholesterol levels
and the cholesterol precursor lathosterol and its oxidative brain
specific metabolites, 24S-hydroxycholesterol and 27-hydroxycho-
lesterol, were measured by gas-chromatography-mass-spectrome-
try-selected ionmonitoring (GC-MS-SIM) as described in detail
previously [66–68]. Brains were homogenized and sterols were
extracted overnight by chloroform/methanol trimethylsilylated
prior to GC-MS-SIM analysis [66,67].
Brain fatty acid analysis. Fatty acid analyses were per-
formed with a part of the brain homogenate (described above).
Total lipid was extracted from brain homogenates by methanol
and chloroform. Subsequently, samples were centrifuged at
3000 rpm for 10 min and the lower phase (chloroform and lipids)
was removed. Chloroform was added to the upper phase, samples
were centrifuged again at 3000 rpm for 10 min and the lower
phase was combined with the first one. The chloroform fractions
were dried in a SpeedVacH and 2 ml methanol and 40 ml
concentrated sulfuric acid were added to the dried extract. The
samples were heated at 100uC for 60 min, and 2 ml hexane and
0.5 ml 2.5 M sodium hydroxide solution were added. After
vortexing and centrifuging the samples for 5 min at 3000 rpm,
the upper layer was collected and evaporated in a SpeedVacH.
The fatty acids (FAs) were dissolved in 125 ml iso-octane and
analyzed on a GC-FID with a CP-SIL88 column (50 m60.25 mm
id. 0.22 film thickness). The n6/n3 ratio was calculated as the sum
of analyzed n6 FAs divided by the sum of n3 FA.
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Quantitative real-time PCR (qRT-PCR). A part of the
frozen brain tissue, including both hippocampi, were collected in
1 ml cold Trizol (Invitrogen, Paisley, UK) and homogenized by
sonification. After chloroform extraction and isopropyl alcohol
precipitation, RNA was dissolved in 25 ml RNase-free DEPC-
treated water. The RNA concentrations were measured with a
Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific Inc,
Wilmington, DE, USA). cDNA synthesis was performed using
1 mg RNA dissolved in 10 ml RNase-free DEPC-treated water
containing 2 ml 56 iScript reaction mix and 0.5 ml iScript reverse
transcriptase (iScript cDNA synthesis kit, Bio-Rad Laboratories
B.V., Veenendaal, The Netherlands) at 25uC for 5 min, at 42uC
for 30 min and at 85uC for 5 min (Eppendorf Thermoblock
Mastercycler 5330).
Quantitative real-time PCR (qRT-PCR) was performed in a
total volume of 10 ml buffer solution containing 2 ml of template
cDNA, 5 ml 26 SYBR Green Master mix (Applied Biosystems,
Foster City, CA, USA), 2.92 ml RNase-free DEPC-treated water
and 0.04 ml of each primer (100 mM). Primers for cluster of
differentiation 36 (CD36), glyceraldehyde-3-phosphate dehydro-
genase (GAPDH), interleukin-1b (IL-1b), interleukin-6 (IL-6),
monocyte chemoattractant protein 1 (MCP-1) and tumor necrosis
factor-a (TNF-a) were designed using Vector Primer Express
software (Applied Biosystems). Primer pairs were as follows:
CD36: 59- ATGGGCTGTGATCGGAACTG-39 and 59-
GTCTTCCCAATAAGCATGTCTCC-39; GAPDH: 59-
AGGTCGGTGTGAACGGATTTG-39 and 59-TGTAGAC-
CATGTAGTTGAGGTCA-39;
IL-1b: 59-GCAACTGTTCCTGAACTCAACT-39 and 59-
ATCTTTTGGGGTCCGTCAACT-39; IL-6: 59-CAAGTCG-
GAGGCTTAATTACACATG-39 and 59-ATTGCCATTGCA-
CAACTCTTTTCT-39; MCP-1: 59-CCCAATGAGTAGGCTG-
GAGA-39 and 59-TCTGGACCCATTCCTTCTTG-39; and
TNF-a: 59-CAGACCCTCACACTCAGATCATCT-39 and 59-
CCTCCACTTGGTCCTTTGCTA-39. The optimal tempera-
ture cycling protocol was determined to be 95uC for 10 min
followed by 40 reaction cycles at 90uC for 15 s and at 60uC for
1 min, using a StepOnePlus real time PCR system (Applied
Biosystems, Foster City, CA, USA). The absolute quantities were
determined using standard curves, and the validity of the results
was checked by running appropriate negative controls. The
quantity of cDNA was calculated for each sample with StepOne
Software version 2.2.2. Relative gene expression ratios, calculated
according to the comparative CT method (also referred to as the
22DCT method) [69], were used to evaluate differences. Relative
CT (DCT) values were calculated by subtracting the CT value of
the housekeeping gene GADPH from the CT values of CD36, IL-
1b, IL-6, MCP-1 or TNF-a. For each primer, two independent
qRT-PCR runs were performed, and the means of their relative
values were used for statistical analysis.
Statistical analysis
Data are expressed as mean 6 SEM and were analyzed with
SPSS for windows 18.0 software (SPSS Inc. Chicago, IL, USA).
The repeated measures ANOVA was used for the acquisition
phase of the MWM and rMWM (with the repeated measure: trial
block), followed by a Bonferroni post hoc to analyze possible
interactions between trial block, genotype and/or diet. If
interactions between trial block, genotype and/or diet (between-
group-factors) were present, the data were split for the concerning
factor and thereafter analyzed again with the repeated measures
ANOVA. Multivariate ANOVA’s (MANOVAs) were conducted
with between group factors: genotype and diet, to analyze possible
differences between wild-type and AbPP-PS1 mice and the
different diet groups in the open field test, the probe trials of the
MWM and rMWM, the body weight and brain weight,
hippocampal metabolite concentrations, the amount of immature
neurons, and the biochemical analyses. If interactions between
genotype and diet (between-group-factors) were present, the data
were split for the concerning factor and thereafter analyzed again
with the MANOVA. If no interactions between the genotype and
diet were present and overall analysis revealed a significant effect
of diet, the separate diet groups were analyzed post hoc by using
Tukey’s HSD test. For clarity reasons, F-values are not displayed.
Furthermore, only between-group interactions that reached
statistical significance are specified in detail. Statistical significance
was set at p,0.05.
Results
Body and brain weight
All mice were weighed one week before starting the behavioral
test battery and again on the day of the MR measurements (1–2
months later). Since body weights within the groups did not
change significantly between those two time points (ANOVA,
p.0.50), the mean weight was used for further statistical analyses.
Body weight was affected by genotype (ANOVA, p,0.001), but
not by dietary intake (ANOVA, p=0.913). No significant
genotype6diet interaction was observed (ANOVA, p=0.164).
Overall mean body weight was 39.660.7 g in the AbPP-PS1 mice
and 35.260.6 g in the wild-type mice. Absolute brain weight was
not affected by genotype (ANOVA, p=0.733) or by diet
(ANOVA, p=0.543). No significant genotype6diet interaction
was observed (ANOVA, p=0.078). Overall mean brain weight
was 0.5360.00 g in AbPP-PS1 animals and 0.5360.01 g in wild-
type mice.
Behavioral analyses
Open field. In the open field, locomotor activity and active
exploration parameters (walking, sitting, wall leaning, rearing) and
grooming were scored for 30 minutes. In addition, total walking
distance, mean walking velocity, and the time spent in the corners
respectively the center of the open field were obtained from the
recorded sessions.
AbPP-PS1 mice were more active in the open field than wild-
type mice, independent of diet (genotype6diet interaction, walking
p=0.777; sitting p=0.857; distance moved p=0.926; velocity
p=0.927). AbPP-PS1 mice walked more (Figure 2A; ANOVA
p=0.015) and sat less (Figure 2B; ANOVA p,0.001) than wild-
type mice. This resulted in an increased distance moved (Figure 2F;
ANOVA p,0.001) and higher mean walking speed in AbPP-PS1
mice compared to wild-type animals (ANOVA p,0.001; wild-type
4.260.1 cm/s, AbPP-PS1 5.160.3 cm/s). Dietary intake affected
the time spent sitting (ANOVA, p=0.015), the distance moved
(ANOVA, p=0.006) and the mean velocity (ANOVA, p=0.006).
Dietary intervention with the FC diet had no effect on these
parameters (post hoc, p.0.05). However, animals fed the DEU
diet sat less than animals fed the CO diet (Figure 2B; post hoc
p=0.025), but did not differ from the mice fed the FC diet (post
hoc, p=0.322). Furthermore, mice fed the DEU diet also traveled
a greater distance (Figure 2F; post hoc p=0.009) with a higher
mean velocity (post hoc, p=0.009; CO diet 4.260.2 cm/s, DEU
diet 5.160.3 cm/s, FC diet 4.560.2 cm/s) than animals fed the
CO diet, but again did not differ from the animals fed the FC diet
(post hoc, p=0.098). Overall analysis revealed a tendency for a
diet effect on the time spent walking (p=0.053), but since this did
not reach statistical significance, no additional post hoc tests were
performed to compare the different diet groups.
Diet Effect on AD Mice Brain Structure & Function
PLOS ONE | www.plosone.org 6 September 2013 | Volume 8 | Issue 9 | e75393
Moreover, AbPP-PS1 mice displayed less explorative behavior
away from the walls of the open field, e.g. rearing (Figure 2C;
ANOVA p=0.030) compared to wild-type animals, but more
explorative behavior against the walls of the open field, e.g. wall
leaning (Figure 2D; ANOVA p,0.001), independent of diet
(genotype6diet interaction, rearing p=0.468; wall leaning
p=0.513). Rearing behavior was not affected by dietary interven-
tion with the DEU and FC diets (ANOVA, p=0.355). Wall
leaning behavior however was affected by diet (ANOVA,
p=0.001). Animals fed the DEU diet leaned more against the
walls of the open field than mice fed the FC diet (Figure 2D; post
hoc p=0.007), and also slightly more than animals fed the CO diet
(post hoc, p=0.070), although this did not reach statistical
significance. No significant differences between wild-type and
AbPP-PS1 mice (Figure 2E; ANOVA p=0.744) nor between the
dietary groups (ANOVA, p=0.620) were observed for grooming
behavior (genotype6diet interaction, p=0.172).
Furthermore, AbPP-PS1 mice spent slightly less time in the
center of the open field than wild-type mice (Figure 2G; ANOVA
p=0.064), although it did not reach statistical significance. No
differences were observed between the dietary groups in the time
spent in the center of the open field (ANOVA, p=0.116). No
genotype6diet interaction was observed for the time spent in the
center of the open field (p=0.356). AbPP-PS1 mice did however
spent significantly more time in the corners of the open field
compared to wild-type animals (Figure 2H; ANOVA p=0.001),
independent of diet (genotype6diet interaction, p=0.085). Dietary
intake affected the time spent in the corners of the open field
(ANOVA, p=0.007), such that animals fed the FC diet spent
significantly less time in the corners of the open field than mice fed
the CO diet (post hoc, p=0.038) and the DEU diet (post hoc,
p=0.033).
Altogether these data show increased activity, but decreased
explorative behavior in AbPP-PS1 mice. Furthermore, AbPP-PS1
mice also display increased anxiety-related behavior, as indicated
by the increased time spent wall leaning and increased time spent
in the corners of the open field [58,70]. Dietary intervention with
the DEU diet increased general locomotor activity and anxiety-
related exploration (e.g. wall leaning) in wild-type and AbPP-PS1
mice. Our results might suggest that the FC diet could have an
anxiolytic effect, since it decreased the time spent in the corners of
the open field in both wild-type and AbPP-PS1 mice.
Morris water maze (MWM). The Morris water maze is
designed to test spatial learning by training the mice to find a
hidden platform (acquisition phase) in a pool. Spatial memory is
tested in a trial in which the platform is removed from the maze
(probe trial) following the last trial of the acquisition phase.
Both AbPP-PS1 and wild-type mice showed a decrease in
escape latency during training (Figure 3A; ANOVA p,0.001). No
significant time6genotype, time6diet or time6genotype6diet
interactions were observed (p.0.05), indicating that all animals
learned the position of the hidden platform equally well. However,
escape latencies were significantly higher in AbPP-PS1 mice
compared to wild-type animals (Figure 3A; ANOVA p,0.001),
independent of dietary intake (genotype6diet interaction,
p=0.097), indicating that spatial learning was affected by
genotype. Escape latencies did not differ between the animals
fed the CO diet, DEU diet or FC diet (Figure 3B; ANOVA
p=0.203). During acquisition training, swim speed decreased in
both AbPP-PS1 and wild-type mice over time (data not shown;
ANOVA p,0.001). No significant time6genotype, time6diet or
time6genotype6diet interactions were observed (p.0.05). How-
ever, the average swim speed was significantly higher in AbPP-PS1
mice compared to wild-type animals during training (ANOVA
p=0.001; wild-type 10.560.3 cm/s; AbPP-PS1 12.560.5 cm/s),
independent of dietary intake (genotype6diet interaction
p=0.652). The mean swim speed did not differ (ANOVA,
p=0.341) between the animals fed the CO diet (11.560.4 cm/
s), DEU diet (10.660.4 cm/s) or FC diet (11.560.6 cm/s).
During the probe trial, AbPP-PS1 mice spent less time in the
target NE quadrant (Figure 3C, ANOVA p=0.033) than wild-type
mice, independent of diet (genotype6diet interaction, p=0.688),
indicating impaired spatial memory. Furthermore, AbPP-PS1
mice also spent less time in the exact area where the platform had
been located (Figure 3D; ANOVA p=0.010) and had a higher
latency to reach the former platform location (Figure 3E; ANOVA
p=0.003) than wild-type animals, independent of diet, again
reflecting impaired spatial memory. Dietary intervention with
DEU and FC had no effect on these parameters of spatial memory
(ANOVA, p.0.05). Overall statistical analysis indicated significant
genotype6diet interactions for the swim distance (p=0.004) and
mean velocity (p=0.004).
Dietary intake affected the swim distance (ANOVA, p=0.014)
and mean velocity (ANOVA, p=0.015) in AbPP-PS1 mice, such
that AbPP-PS1 mice on the FC diet displayed a shorter swim
distance (Figure 3F; post hoc p=0.013) and lower mean swim
velocity than the AbPP-PS1 animals on CO diet (post hoc,
p=0.015; AbPP-PS1-CO diet 17.360.4 cm/s, AbPP-PS1-FC diet
13.861.2 cm/s), and compared to the wild-type animals on FC
diet (ANOVA, p=0.009; wild-type-FC diet 16.960.4 cm/s), but
not compared to the AbPP-PS1 animals on DEU diet (post hoc,
p=0.079; AbPP-PS1-DEU diet 16.860.9 cm/s).
Reverse Morris water maze (rMWM). In the reverse
Morris water maze (rMWM), mice have to learn to find a novel
position for the hidden platform. This task is considered to be a
test for new learning abilities, in which a previous successful
strategy must be inhibited and a new strategy should be developed.
Both AbPP-PS1 and wild-type mice showed a decrease in
escape latency during training (Figure 4A; ANOVA p=0.016). No
significant time6genotype, time6diet or time6genotype6diet
interactions were observed (p.0.05), indicating that all animals
learned the new platform position equally well. Escape latencies
did not differ between AbPP-PS1 and wild-type mice (Figure 4A;
ANOVA p=0.160), nor did they differ between the animals on
CO diet, DEU diet and FC diet (Figure 4B; ANOVA p=0.274).
No genotype6diet interaction was observed for the escape
latencies (p=0.922).
During acquisition training with a new platform location, swim
speed decreased in both AbPP-PS1 and wild-type mice over time
(data not shown; ANOVA p,0.001). No significant time6
genotype, time6diet or time6genotype6diet interactions were
observed (p.0.05). However, the average swim speed was
significantly higher in AbPP-PS1 mice compared to wild-type
animals during revere MWM training (ANOVA p=0.008; wild-
type 5.760.2 cm/s; AbPP-PS1 6.860.4 cm/s), independent of
dietary intake (genotype6diet interaction p=0.827). The mean
swim speed did not differ (ANOVA, p=0.511) between the
animals fed the CO diet (5.960.3 cm/s), DEU diet (6.560.4 cm/
s) or FC diet (6.060.4 cm/s).
During the probe trail, AbPP-PS1 mice spent less time in the
target SW quadrant (Figure 4C; ANOVA p=0.006) than wild-
type mice, independent of diet (genotype6diet interaction,
p=0.120), although all animals performed well above 25% chance
level, indicating good memorization of the platform quadrant.
However, AbPP-PS1 mice also spent less time in the exact area
where the platform had been located after relocation (Figure 4D;
ANOVA p,0.001), indicating impaired spatial memory. Further-
more, they displayed a slightly higher latency to reach the former
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platform location than wild-type animals (Figure 4E; ANOVA
p=0.054), although this did not reach statistical significance.
Dietary intervention with DEU and FC had no effect on these
parameters of spatial memory (ANOVA, p.0.05). No differences
were observed between AbPP-PS1 and wild-type animals in the
swim distance (Figure 4F; ANOVA p=0.909) or in the mean swim
velocity (ANOVA p=0.918; wild-type 16.360.2 cm/s, AbPP-PS1
16.260.4 cm/s). Overall statistical analysis indicated a significant
Figure 2. Open field behavior of 11-month-old AbPP-PS1 and wild-type mice on control and specific multi-nutrient diets. Open field
parameters were measured within a 30 min period. A: AbPP-PS1 mice spent more time walking than wild-type mice (*p=0.015). Walking was not
affected by dietary intake. B: AbPP-PS1 mice spent less time sitting than wild-type mice (*p,0.001). Animals on the DHA, EPA and UMP (DEU) diet sat
let than animals on control (CO) diet (a* p=0.025), but did not differ from the mice on the FortasynH Connect (FC) diet. C: AbPP-PS1 mice spent less
time rearing than wild-type mice (*p=0.030). Rearing behavior was not affected by dietary intake. D: AbPP-PS1 mice spent more time wall leaning
than wild-type mice (*p,0.001). Animals fed the DEU diet leaned more against the walls than mice fed the FC diet (c* p=0.007), and also slightly
more than animals fed the CO diet (a# p= 0.070), although this did not reach statistical significance. E: Grooming behavior was similar among wild-
type and AbPP-PS1 mice, and was not affected by dietary intake. F: AbPP-PS1 mice traveled a longer distance than wild-type mice (*p,0.001). Mice
fed the DEU diet traveled a greater distance than animals fed the CO diet (a* p= 0.009), but did not differ from the animals fed the FC diet. G: AbPP-
PS1 mice spent slightly less time in the center of the open field than wild-type mice (#p=0.064), although this did not reach statistical significance.
The time spent in the center of the open field was not affected by dietary intake. H: AbPP-PS1 mice spent more time in the corners of the open field
compared to wild-type mice (*p= 0.001). Animals fed the FC diet spent less time in the corners of the open field than mice fed the CO diet (a*
p= 0.038) and animals fed the DEU diet (b* p=0.033).
doi:10.1371/journal.pone.0075393.g002
Diet Effect on AD Mice Brain Structure & Function
PLOS ONE | www.plosone.org 8 September 2013 | Volume 8 | Issue 9 | e75393
effect of diet on swim distance (ANOVA, p=0.030) and mean
swim velocity (ANOVA p=0.031; CO diet 16.660.3 cm/s, DEU
diet 16.560.3 cm/s, FC diet 15.660.5 cm/s). However, Tukey’s
post hoc analysis revealed no significant differences between any of
the diet groups (post hoc, p.0.1).
Magnetic resonance imaging (MRI)
Magnetic resonance spectroscopy (MRS). To determine
hippocampal metabolite concentrations, single voxel 1H MRS at
11.7 T was used (Figure 5). No differences were observed between
wild-type and AbPP-PS1 mice (Figure 5A), nor between the
different diet groups (Figure 5B) in the levels of creatine and
phosphocreatine (tCre; ANOVA p.0.05). Therefore, tissue
concentrations of metabolites are given relative to tCre as applied
by others [71,72].
AbPP-PS1 mice had significantly lower levels of N-acetylaspar-
tate and N-acetylaspartylglutamate (tNAA; ANOVA p=0.030)
than wild-type mice, independent of diet (genotype6diet interac-
tion, p=0.513), indicating decreased neuronal integrity
(Figure 5A). Wild-type and AbPP-PS1 mice had similar levels of
choline-containing compounds (tCho; ANOVA p=0.079), gluta-
mine and glutamate (Glx; ANVOA p=0.963), myo-Inositol and
glycine (mI+Gly; ANOVA p=0.196) and taurine (Tau; ANOVA
p=0.475).
Statistical analysis indicated a significant effect of dietary intake
on tCho levels, independent of genotype (Figure 5B; ANOVA
p=0.035). Post hoc analysis revealed that animals fed the FC diet
Figure 3. Morris water maze performance of 11-month-old AbPP-PS1 and wild-type mice on control and multi-nutrient diets. Spatial
learning was measured in a 4-day acquisition phase, by determining the latency to find a hidden platform in the NE quadrant. Spatial memory was
tested in the probe phase in which the percentage of time spent in the target NE quadrant, the time spent in the former platform area, the latency to
the former platform area and the total distance moved were measured. A: Both AbPP-PS1 and wild-type mice showed a decrease in latency during
training. Overall escape latencies were higher in AbPP-PS1 mice (*p,0.001), independent of dietary intake. B: Animals on control (CO), the DHA, EPA
and UMP (DEU) and FortasynH Connect (FC) diets showed a similar decrease in latency during training, independent of genotype. Overall escape
latencies were not affected by dietary intake. C: AbPP-PS1 mice spent less time in the target NE quadrant than wild-type mice, independent of dietary
intake (*p=0.033). Time spent in the NE quadrant was unaffected by dietary intake. D: AbPP-PS1 mice spent less time in the former platform area
than wild-type mice (*p= 0.010), independent of dietary intake. Time spent in the exact former platform area was unaffected by dietary intake. E:
AbPP-PS1 mice had a higher latency to reach the former platform location than wild-type mice (*p= 0.003), independent of dietary intake. Latency to
reach the former platform location was unaffected by dietary intake. F: AbPP-PS1 mice on FC diet displayed a shorter swim distance compared to
wild-type mice on FC diet (*p=0.009) and compared to AbPP-PS1 mice on CO diet (*p= 0.013), but not compared to AbPP-PS1 mice on DEU diet.
doi:10.1371/journal.pone.0075393.g003
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had significant lower tCho levels than animals fed the CO diet
(post hoc, p=0.039), but no difference compared to the animals
fed the DEU diet (post hoc, p=0.228). No differences were
observed between the different diets in relative concentrations of
Glx (ANOVA, p=0.627), mI+Gly (ANOVA, p=0.400), tNAA
(ANOVA, p=0.156) and Tau (ANOVA, p=0.523).
Immunohistochemistry
Doublecortin staining. Immature neurons were visualized
with a polyclonal antibody against doublecortin. Doublecortin-
positive (Dcx+) cells were counted in three alternating hippocam-
pal sections as a measure for neurogenesis.
Overall statistical analysis indicated a significant genotype6diet
interaction (ANOVA, p=0.004) for the relative amount of Dcx+
cells. In wild-type animals, the relative amount of Dcx+ cells were
similar for all diet groups (ANOVA, p=0.530). However, in
AbPP-PS1 mice, the relative amount of Dcx+ cells was affected by
dietary intake (ANOVA, p=0.017). Post hoc analysis revealed that
AbPP-PS1 mice on CO diet showed a decreased amount of Dcx+
cells compared to wild-type mice on CO diet (Figure 6; ANOVA,
p=0.004), indicating decreased neurogenesis in AbPP-PS1 mice
on a normal control diet. Moreover, AbPP-PS1 mice fed the FC
diet had a significantly higher relative amount of Dcx+ cells than
AbPP-PS1 animals fed the CO diet (post hoc, p=0.015),
suggesting that the FC diet restored neurogenesis in AbPP-PS1
Figure 4. Reverse Morris water maze in 11-month-old AbPP-PS1 and wild-type mice on control and multi-nutrient diets. Spatial
learning with an extra episodic memory component was measured in a 2-day acquisition phase, by determining the latency to find a hidden platform
in the SW quadrant. Spatial memory was tested in the probe phase in which the percentage of time spent in the target SW quadrant, the time spent
in the former platform area, the latency to the former platform area and the total distance moved were measured. A: Both AbPP-PS1 and wild-type
mice showed a decrease in latency during training, independent of dietary intake. Overall escape latencies did not differ between AbPP-PS1 and wild-
type mice. B: Animals on control (CO), the DHA, EPA and UMP (DEU) and FortasynH Connect (FC) diets showed a similar decrease in latency during
training, independent of genotype. Overall escape latencies were unaffected by dietary intake. C: AbPP-PS1 mice spent less time in the target SW
quadrant than wild-type mice, independent of dietary intake (*p=0.006), although all animals performed well above 25% chance level. Time spent in
the SW quadrant was unaffected by dietary intake. D: AbPP-PS1 mice spent less time in the former platform area than wild-type mice (*p,0.001),
independent of dietary intake. Time spent in the exact former platform area was unaffected by dietary intake. E: AbPP-PS1 mice had a slightly higher
latency to reach the former platform location than wild-type mice (#p= 0.054), although this did not reach statistical significance. Latency to reach
the former platform location was unaffected by dietary intake. F: No differences were observed between AbPP-PS1 and wild-type animals in the swim
distance. Overall statistical analysis indicated a significant diet effect on the swim distance (p= 0.030). However, Tukey’s post hoc analysis revealed no
significant differences between any of the diet groups.
doi:10.1371/journal.pone.0075393.g004
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mice. Furthermore, AbPP-PS1 mice on FC diet also had a slightly
higher relative amount of Dcx+ cells than wild-type animals on FC
diet (ANOVA, p=0.053), although this did not reach statistical
significance.
Biochemical analyses
Serum and brain sterol analysis. Brain cholesterol levels
(Figure 7A) were similar between wild-type and AbPP-PS1 mice
(ANOVA, p=0.369), and between the diet groups (ANOVA,
p=0.637). However, dietary intervention significantly affected
serum cholesterol levels (Figure 7B) in wild-type mice (ANOVA,
p,0.001), but not in AbPP-PS1 mice (ANOVA, p=0.314), as
indicated by a significant genotype6diet interaction (p=0.009).
Post hoc analysis revealed that in wild-type mice the DEU diet
decreased serum cholesterol levels compared to the CO diet (post
hoc, p=0.014), and the FC diet decreased serum cholesterol levels
further (post hoc, p,0.001 compared to CO diet and p=0.026
compared to DEU diet). No genotype effects on serum cholesterol
levels were observed between the wild-type and AbPP-PS1 mice
on CO (ANOVA, p=0.101) and DEU diets (ANOVA, p= 0.353),
but AbPP-PS1 mice on FC diet had significantly higher serum
cholesterol levels than wild-type mice on FC diet (ANOVA,
p=0.007).
In addition, brain levels of lathosterol (Figure 7C), a main
cholesterol precursor in the ‘‘de novo’’ synthesis pathway, were
similar between wild-type and AbPP-PS1 mice (ANOVA,
p=0.800). Dietary intake did affect the brain levels of lathosterol
(ANOVA, p=0.003), such that animals fed the DEU (post hoc,
p=0.003) and FC diets (post hoc, p=0.010) displayed significantly
decreased levels of brain lathosterol compared to animals fed the
CO diet, independent of genotype (genotype6diet interaction,
p=0.888). Serum lathosterol levels (Figure 7D) were similar
Figure 5. Hippocampal neurochemical profile of 12-month-old AbPP-PS1 and wild-type mice on control and specific multi-nutrient
diets. The neurochemical profile of the hippocampus was determined with single voxel 1H MRS at 11.7 Tesla. A: AbPP-PS1 mice showed a significant
decrease in tNAA/tCre compared to wild-type mice (*p=0.030), independent of dietary intake. AbPP-PS1 and wild-type mice displayed similar levels
of tCho/tCre, tCre, Glx/tCre,mI+Gly/tCre and Tau/tCre. B: Both wild-type and AbPP-PS1 mice fed the FortasynH Connect (FC) diet showed a significant
decrease in tCho/tCre levels compared to animals fed the control (CO) diet (*p= 0.039), but no difference compared to mice fed the DHA, EPA and
UMP (DEU) diet. Dietary intake did not affect the levels of tCre, Glx/tCre, mI+Gly/tCre, tNAA/tCre and Tau/tCre. Values represent the mean and SEM.
tCho= choline-containing compounds; tCre = creatine and phosphocreatine; Glx = glutamine and glutamate; mI+Gly =myo-Inositol and glycine;
tNAA=N-acetylaspartate and N-acetylaspartylglutamate; Tau= taurine.
doi:10.1371/journal.pone.0075393.g005
Figure 6. Neurogenesis in 12-month-old AbPP-PS1 and wild-
type mice on control and specific multi-nutrient diets. From 2
months of age, mice were fed either a control (CO), a DHA, EPA and
UMP (DEU) or a FortasynH Connect (FC) diet. The amount of immature
neurons in the subgranular zone of the hippocampus were visualized
immunohistochemically with a polyclonal goat anti-doublecortin
antibody (1:3000) as a measure for neurogenesis. Values represent
the mean and SEM and are relative (%) compared to wild-type mice on
CO diet. In wild-type animals, the relative amount of doublecortin-
positive (Dcx+) immature neurons was similar for all diet groups.
However, in AbPP-PS1 mice the relative amount of Dcx+ immature
neurons was affected by dietary intake (p= 0.017). Post hoc analysis
revealed that AbPP-PS1 mice fed the CO diet displayed a significantly
decreased relative amount of Dcx+ immature neurons compared to
wild-type mice on the CO diet (*p= 0.004). The FC diet significantly
increased the relative amount of Dcx+ immature neurons in AbPP-PS1
mice as compared to AbPP-PS1 mice on CO diet (*p = 0.015).
Furthermore, AbPP-PS1 mice on the FC diet had slightly higher relative
amount of Dcx+ immature neurons than wild-type animals on the FC
diet (#p=0.053), although this did not reach statistical significance.
doi:10.1371/journal.pone.0075393.g006
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between wild-type and AbPP-PS1 mice (ANOVA, p=0.609), and
between the diet groups (ANOVA, p=0.709).
Furthermore, the levels of cholesterol’s brain specific oxidative
metabolite 24S-hydroxycholesterol did not differ significantly in
the brains (ANOVA, p=0.072) and sera (ANOVA, p=0.510) of
Figure 7. Sterol levels in 12-month-old AbPP-PS1 and wild-type mice on control and specific multi-nutrient diets. Sterol levels were
determined in brain homogenates and blood serum by gas-chromatography-mass-spectrometry-selected ionmonitoring. A–B: Cholesterol levels
were similar in the brains of AbPP-PS1 and wild-type mice and were unaffected by dietary intake. In blood sera of wild-type mice, the FortasynH
Connect (FC) diet decreased cholesterol levels as compared to the control (CO) and the DHA, EPA and UMP (DEU) diets (**), whereas the DEU diet led
to intermediate cholesterol levels as compared to the CO and FC diets. Only wild-type mice on FC diet displayed decreased levels of serum
cholesterol compared to AbPP-PS1 mice, *p,0.05. C-D: Lathosterol levels were similar in the brains and blood sera of AbPP-PS1 and wild-type mice.
Serum lathosterol levels were unaffected by dietary intake, but brain lathosterol levels were decreased in AbPP-PS1 and wild-type mice on the DEU
and FC diets as compared to the CO diet (a* p,0.05). E–F: 24-hydroxycholesterol levels were similar in the brains and blood sera of AbPP-PS1 and
wild-type mice. Brain 24-hydroxycholesterol levels were increased in AbPP-PS1 and wild-type mice on the DEU and FC diets as compared to the CO
diet (a*), whereas serum 24-hydroxycholesterol levels were decreased in AbPP-PS1 and wild-type mice on the DEU and FC diets as compared to the
CO diet (a*), a*p,0.05. G–H: Brain 27-hydroxycholesterol levels were decreased in AbPP-PS1 mice compared to wild-type mice (*p= 0.040), but were
unaffected by dietary intake. Serum 27-hydroxycholesterol levels were similar between AbPP-PS1 and wild-type mice, independent of dietary intake.
Overall analysis revealed a tendency for an effect of dietary intake (p=0.054), but no post hoc analyses were performed since it did not reach
statistical significance.
doi:10.1371/journal.pone.0075393.g007
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wild-type and AbPP-PS1 mice. Dietary intake did affect both
brain (ANOVA, p,0.001) and serum (ANOVA, p=0.001) 24S-
hydroxycholesterol levels, such that animals fed the DEU (post
hoc, p=0.004) and FC diets (post hoc, p,0.001) had significantly
higher levels of 24S-hydroxycholesterol in the brain compared to
animals fed the CO diet (Figure 7E), independent of genotype
(genotype6diet interaction, p=0.054), indicating increased con-
version of cholesterol in the brain due to dietary intervention. In
contrast, serum 24S-hydroxycholesterol levels (Figure 7F) were
decreased in animals fed the DEU (post hoc, p=0.028) and FC
diets (post hoc, p,0.001) compared to animals fed the CO diet,
independent of genotype (genotype6diet interaction, p=0.477).
Another oxidative metabolite of cholesterol, 27-hydroxycholes-
terol (Figure 7G), was significantly decreased in the brains of
AbPP-PS1 mice compared to wild-type animals (ANOVA,
p=0.040), independent of diet (genotype6diet interaction,
p=0.817), suggesting a decreased flux of cholesterol from the
periphery into the brain [73–75]. No significant differences could
be observed in the levels of brain 27-hydroxycholesterol between
the diet groups (ANOVA, p=0.073). Serum 27-hydroxycholes-
terol levels (Figure 7H) were similar between wild-type and AbPP-
PS1 mice (ANOVA, p=0.256). Overall analysis revealed a
tendency for an effect of diet intervention (ANOVA, p=0.054)
on serum 27-hydroxycholesterol levels, but this did not reach
statistical significance.
Brain fatty acid analysis
Dietary intake affected the relative concentrations of oleic acid
(ANOVA, p=0.011), arachidonic acid (ANOVA, p,0.001),
docosahexaenoic acid (ANOVA, p,0.001), omega-3 fatty acids
(n3 FAs; ANOVA p,0.001), and omega-6 FAs (ANOVA;
p,0.001) in both wild-type and AbPP-PS1 mice (Figure 8).
Animals fed the DEU and FC diets (post hoc p,0.001) showed a
shift in the balance between n3 and n6 fatty acids as compared to
animals fed the CO diet (main ANOVA diet effect, p,0.001). The
relative amount of n3 FA in DEU and FC fed mice increased
compared to the CO diet (post hoc, p,0.001), whereas the relative
amount of n6 decreased (post hoc, p,0.001), resulting in a
pronounced shift in the n3/n6 ratio in DEU and FC fed mice in
favor of the n3 FA. The reduction of the relative n6 content was
mainly caused by a relative decrease in arachidonic acid (AA;
C20:4n6; post hoc p,0.001), while the higher n3 content
originated from a relative increase in DHA (C22:6n3; post hoc
p,0.001) in both the DEU and FC fed animals as compared to the
CO fed animals. Furthermore, the relative concentration of oleic
acid (OA; C18:1n9) was significantly increased in the DEU fed
mice (post hoc, p=0.005), and also slightly increased in the FC fed
animals (post hoc, p=0.066) as compared to the CO diet, although
it did not reach statistical significance.
No significant differences were observed between the DEU and
FC diets in any fatty acid analyzed (post hoc, p.0.05). The relative
amounts of palmitic acid (C16:0; ANOVA p=0.714), stearic acid
(C18:0; ANOVA p=0.841), total saturated fatty acids (SFA;
ANOVA p=0.793), total mono-unsaturated fatty acids (MUFA;
ANOVA p=0.316) and total poly-unsaturated fatty acids (PUFA;
ANOVA p=0.459) were unaffected by the diets (data not shown).
No significant genotype effects or genotype6diet interactions were
found for any of the fatty acids analyzed (ANOVA, p.0.05).
Quantitative real-time PCR (qRT-PCR). Wild-type and
AbPP-PS1 mice displayed similar levels of MCP-1 (ANOVA,
p=0.927), IL-6 (ANOVA, p=0.081), TNF-a (ANOVA, p=0.701)
and CD36 (ANOVA, p=0.180). However, IL-1b levels were
significantly increased in AbPP-PS1 mice compared to wild-type
animals (Figure 9A; ANOVA, p,0.001), independent of dietary
intake (genotype6diet interaction, p=0.272). Furthermore, overall
statistical analysis indicated a significant effect of dietary intake on
the levels of IL-1b (ANOVA, p=0.005). Post hoc analysis revealed
that both wild-type and AbPP-PS1 animals fed the DEU (post hoc,
p=0.034) and FC diets (post hoc, p=0.013) had significantly
higher levels of IL-1b than animals fed the CO diet (Figure 9B).
No differences were observed between the different diets in the
levels of MCP-1 (ANOVA, p=0.349), IL-6 (ANOVA, p=0.232),
TNF-a (ANOVA, p=0.707) and CD36 (ANOVA, p=0.157).
Discussion
In the present study, we investigated the extent to which long-
term consumption of two specific multi-nutrient enriched diets,
developed to support membrane synthesis and maintenance, can
modulate behavior, cognition, hippocampal metabolite levels,
neurogenesis and inflammation in 11-12-month-old AbPP-PS1
mice. An overview of the main results found in the current study is
shown in Table 3.
In agreement with previous results from our lab [58,76], 11-
month-old AbPP-PS1 mice displayed increased activity and
anxiety-related behavior, and decreased explorative behavior in
Figure 8. Brain fatty acids in 12-month-old AbPP-PS1 and wild-type mice on control and specific multi-nutrient diets. The relative
concentrations of different fatty acids were determined in the lipid fraction of brain homogenates, and were similar between AbPP-PS1 and wild-type
mice. Dietary intake affected the relative concentrations of different fatty acids similarly in AbPP-PS1 and wild-type mice. Both the DHA, EPA and UMP
(DEU) diet and the FortasynH Connect (FC) diet increased the relative concentrations of omega-3 fatty acids (n3) and decreased the relative
concentrations of omega-6 fatty acids (n6), resulting in a pronounced shift in n3/n6 ratio in favor of the n3 fatty acids as compared to the control(CO)
diet, *p,0.001. The reduction of the relative n6 content was mainly caused by a decrease in arachidonic acid (AA; C20:4n6), while the higher n3
content was mainly caused by an increase in docosahexaenoic acid (DHA; C22:6n3), *p,0.001. The relative concentration of oleic acid (OA; C18:1n9)
was increased due to intake of the DEU diet *p=0.005), while it was only slightly, but not significantly, increased due to intake of the FC diet
(#p= 0.066). The relative amount of palmitic acid (C16:0); stearic acid (C18:0), saturated fatty acids, mono-unsaturated fatty acids and poly-
unsaturated fatty acids were unaffected by dietary intake (data not shown).
doi:10.1371/journal.pone.0075393.g008
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the open field as compared to age-matched wild-type mice.
Hyperactivity and decreased explorative behavior are specific
characteristics of many AbPP transgenic mice [77–79] and may be
explained as a result of elevated anxiety levels [80,81]. Curiosity
motivates mice to explore a novel environment, but this
exploratory drive is in conflict with fear of the unknown.
Hyperactivity and anxiety-related behavior in AbPP transgenic
mice resemble anxiety symptoms and restlessness, which occur in
up to 70% of AD patients during the course of their illness and are
significantly correlated with impairments in activities of daily living
[82–84]. Dietary intervention with the DEU and FC diets
differentially affected open field behavior in both AbPP-PS1 and
wild-type mice. While the DEU diet increased general locomotor
activity (restlessness) and anxiety-related exploration (e.g. wall
leaning), our results suggest that the FC diet could have an
anxiolytic effect, since it decreased the time spent in the corners of
the open field as compared to the animals on CO and DEU diets.
Previous studies have shown that rats fed an n3 lc-PUFA deficient
diet display increased anxiety-related behavior in the open field
and elevated plus maze tasks as compared to animals fed an n3 lc-
PUFA adequate diet [85,86]. Supplementation with n3 lc-PUFAs
led to substantial reduction in the anxiety levels of n3 lc-PUFA
deficient rats [86,87] and mice [88]. Moreover, n3 fatty acid
deficiency has been linked to increased vulnerability to stress,
elevated aggression, and increased depressive-like symptoms in
rodents [89]. Supplementation with n3 lc-PUFAs has also shown
beneficial effects on depressive symptoms and agitation in patients
with mild to moderate AD [90]. However, it should be noted that
both the DEU diet and the FC diet contained equal amounts of n3
lc-PUFAs, suggesting that the combination of additional nutrients
in the FC diet was important for the efficacy on anxiety-related
behavior. Interestingly, Schipper et al. showed that a combination
of n3 lc-PUFAs, phospholipids and B-vitamins (which are also part
of the current FC diet) completely abolished anxiety-related
behavioral responses, increased social behavior and facilitated fear
extinction recall in serotonin transporter knockout (SERT-ko) rats
[91]. Furthermore, the FC diet also reduced anxiety-related
behavior in the open field in 12-month-old apolipoprotein E
(apoE)-e4/e4 and apoE knockout mice [92]. Combined, these
results suggest that supplementation with the FC diet could
potentially be beneficial for several neurodegenerative and
neurological disorders in which patients exhibit symptoms of
agitation, anxiety and depression.
In line with our previous results [58,76], 11-month-old AbPP-
PS1 mice also showed impaired performance in the MWM and
rMWM as compared to age-matched wild-type animals. Although
both AbPP-PS1 and wild-type mice showed a similar decrease in
escape latency during training in the MWM, overall escape
latencies were significantly higher in AbPP-PS1 mice, independent
of dietary intake. Longer escape latencies during spatial navigation
can be caused by slower swim speed, although this is not a
confounding factor in the current study, since AbPP-PS1 mice
displayed higher swim speeds during the task acquisition trials.
Longer escape latencies during spatial navigation may also be
caused by the use of certain, less efficient, search strategies, such as
a constant random search of the entire surface area of the pool,
which would indicate a complete lack of spatial learning abilities,
or by persistent performance of a less efficient than spatial (direct)
Figure 9. Inflammatory markers in 12-month-old AbPP-PS1 and wild-type mice on control and specific multi-nutrient diets.
Inflammatory markers were determined by quantitative real-time PCR in a part of the snap-frozen brain tissue, which included both hippocampi,
using primers for monocyte chemoattractant protein 1 (MCP-1), interleukin-1b (IL-1b), interleukin-6 (IL-6), tumor necrosis factor-a (TNF-a), cluster of
differentiation 36 (CD36), and glyceralehyde-3-phospate dehydrogenase (GADPH). Relative gene expression ratios were calculated according to the
comparative CT method (2
2DCT method), by subtracting the CT value of the housekeeping gene GADPH from the CT values of the inflammatory
markers(DCT). A: AbPP-PS1 and wild-type mice displayed similar levels of MCP-1, IL-6, TNF-a and CD36. However, IL-1b levels were increased in AbPP-
PS1 mice compared to wild-type animals, independent of dietary intake (*p,0.001). B: Levels of MCP-1, IL-6, TNF-a and CD36 were unaffected by
dietary intake. However, the levels of IL-1b were affected by dietary intake, independent of genotype (p=0.005). Both the DHA, EPA and UMP (DEU)
diet (p=0.034) and the FortasynHConnect (FC) diet (p=0.013) increased the levels of IL-1b as compared to the control (CO) diet in AbPP-PS1 and
wild-type mice.
doi:10.1371/journal.pone.0075393.g009
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search strategy, such as circling the pool at a certain distance from
the wall to find the platform [93,94]. In this strategy, mice have
not used the spatial cues to learn the location of the platform,
although such a strategy would result in a successful location of the
escape platform during training. Since AbPP-PS1 mice searched
the target NE quadrant during the probe trial at chance level (25%
or less), our results might imply that the AbPP-PS1 mice made use
of a random or a persistent non-spatial search strategy to locate the
platform during acquisition training. This is in line with a study by
O9Leary and Brown, in which the search strategies used by 16-
month-old AbPP-PS1and wild-type mice during visuo-spatial
navigation in the Barnes Maze were analyzed [95]. 16-month-
old AbPP-PS1 mice predominantly made use of a random search
strategy to locate the escape hole in the Barnes Maze, whereas
wild-type mice predominantly made use of a spatial (direct and
accurate) search strategy. Similar results have been found for the
search strategies used by the TgCRND8 transgenic AbPP mouse
model in the MWM test [96,97]. Moreover, it was shown that
C57BL6 mice, treated with Temozolomide (TMZ) to suppress
adult hippocampal neurogenesis, displayed a delayed (or even
absent) use of directed and place specific search patterns in the
(reversal) MWM test compared to untreated mice, suggesting that
hippocampal neurogenesis is necessary for adding flexibility to
some hippocampus-dependent qualitative parameters of learning
[93]. Consistent with our current findings, reduced hippocampal
neurogenesis has been found previously in AbPP-PS1 mice [98–
100] and in AD patients [101,102], and might underlie some
aspects of the cognitive deficits in AD.
In line with our previous findings [76], AbPP-PS1 and wild-type
mice showed a similar decrease in escape latency during training
in the reversal MWM. The reversal task requires selective memory
retrieval of the newly learned location of the platform, and
Table 3. Overview of the main genotype and diet effects found in the current study.
Effects of genotype: Compared to wild-type mice
AbPP-PS1 mice
Open field Behavior & activity Increased activity & anxiety-related behavior
Decreased exploration
Morris water maze Learning & memory Decreased learning & memory
reverse MWM Learning & memory Decreased memory
Hippocampal 1H MRS Metabolite levels Decreased tNAA/tCre
Immature neurons Hippocampus Decreased neurogenesis
Sterol analyses Serum n.s.
Brain Decreased 27-hydroxycholesterol
Fatty acid analysis Brain n.s.
Inflammatory markers Brain Increased IL-1b
Effects of specific multi-nutrient diets: Compared to littermates on control (CO) diet
DEU diet FC diet
Open field Behavior & activity Increased activity n.s.
Increased anxiety Decreased anxiety
Morris water maze Learning & memory n.s. n.s.
reverse MWM Learning & memory n.s. n.s.
Hippocampal 1H MRS Metabolite levels n.s. Decreased tCho/tCre
Immature neurons Hippocampus n.s. Increased
*effect in AbPP-PS1 only neurogenesis*
Sterol analyses Serum Decreased cholesterol* Decreased cholesterol*
*effect in wild-type only Decreased 24S- Decreased 24S-
hydroxycholesterol hydroxycholesterol
Brain Decreased lathosterol Decreased lathosterol
Increased 24S- Increased 24S-
hydroxycholesterol hydroxycholesterol
Fatty acid analysis Brain Increased n3 content Increased n3 content
Decreased n6 content Decreased n6 content
Increased OA content Increased OA content #
Inflammatory markers Brain Increased IL-1b Increased IL-1b
1H MRS =proton magnetic resonance spectroscopy; tNAA=N-acetylaspartate and N-acetylaspartylglutamate; tCre = creatine and phosphocreatine; IL-1b= interleukin-
1b; DEU diet =DHA, EPA, UMP diet; FC diet = FortasynH Connect diet; tCho= choline-containing compounds; n3 = omega-3 fatty acids; n6 = omega-6 fatty acids;
OA=oleic acid (18:1n9); n.s. = not significant; #= tendency (0.5.p,0.7).
doi:10.1371/journal.pone.0075393.t003
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contains therefore an extra episodic component [60,103]. Since
episodic memory impairment is a major characteristic in early AD
[104–106], our results in AbPP-PS1 mice resemble the problems
that are present in early AD patients. Noteworthy are the relatively
low escape latencies of both AbPP-PS1 and wild-type mice during
the initial trials of the rMWM acquisition training. Although wild-
type mice displayed good short-term spatial memory for the NE
platform location during the probe trial of the MWM, it appears
that this information might not have been sufficiently consolidated
in the long-term memory since they displayed more ‘‘random’’
search behavior during the initial rMWM trials (resulting in lower
escape latencies) than expected if animals had good long-term
memory for the former platform location. One possible explana-
tion could be that the MWM task as used in the current study was
slightly too difficult to optimally master within 4 days of training.
For mice, a MWM pool with a diameter of 120 cm and a platform
of 10–12 cm in diameter (or even larger) is commonly used,
resulting in a search area to target size of 144:1 to 100:1 (or even
lower). In the current study, we used a pool with a diameter of
104 cm and a platform of 8 cm in diameter, resulting in a search
area to target size of 169:1, thereby increasing the MWM task
difficulty [107,108].
Previous studies have shown that n3 lc-PUFA intake may
improve cognition in both mice and rats [58,109,110]. Besides n3
lc-PUFAs, other nutrients can also affect spatial memory
performance. Supplementing CDP-choline or UMP and choline
to rats improved spatial memory in the water maze [111,112]. In
addition, transgenic mice fed vitamin E [113] or vitamin B3 [114]
showed normalized escape latency in the water maze. Further-
more, a combination of vitamin E and folic acid prevented human
Ab1-40-induced impairment of water maze learning in 3-month-
old male Swiss mice [115]. However, in agreement with our
current results, there are also some reports showing no effect of n3
lc-PUFA intake on learning and memory performance
[89,116,117]. Moreover, most intervention studies based on single
nutrient supplementation with n3 lc-PUFAs, B-vitamins or vitamin
E have failed to show any protective effect on AD [39–41,118] or
cognitive decline [119–121], except in some patients with mild AD
[122,123]. Interestingly, clinical studies with the multi-nutrient FC
supplementation have shown beneficial effects on memory
performance in patients with mild AD [51–53], although we
could not replicate these findings in our AbPP-PS1 mouse model
when using the standard conventional measures of performance in
the MWM. However, the FC diet did recently improve the search
strategy of AbPP-PS1 mice in the acquisition of the MWM, by
switching from predominantly random search strategies towards a
more efficient search strategy, suggesting some beneficial effects of
the FC diet on the ability to cope with cognitive impairment in the
AbPP-PS1 mouse model [124].
1H MR spectroscopy revealed decreased tNAA/tCre levels in
the hippocampus of 12-month-old AbPP-PS1 mice as compared to
wild-type mice, in accordance with our previous results [76]. The
reduction of tNAA levels is one of the most consistent findings
using 1H MRS in AD patients [125–128] and in several transgenic
AbPP animals models for AD [129–133], and is commonly
interpreted as a result of neuronal dysfunction or neuronal loss
[134,135]. Furthermore, many previous 1H MRS studies have
found elevated levels of myo-Inositol (mI) in the temporal, parietal
and occipital lobes of AD patients [126,128], which has been
associated with enhanced inflammatory processes. Reports on mI
levels in transgenic animals models are highly inconsistent, since
disturbances in mI levels were found to occur at different ages in
different transgenic species apparently depending on the interplay
of mouse strain, transgene and disease progression [136]. For
example, the AbPPswe (Tg2576) model and the AbPP-PS2N1411
(PS2APP) model do not show any change in mI levels throughout
life compared to age-matched wild-type mice, even though these
animal models display decreased NAA levels in the frontal cortex
at 19–24 months of age, when Ab deposits are widespread
[129,137]. In the case of the AbPPswe-PS1M146L model, one
study reported the most profound increase in mI levels after 20
months of age [130], whereas another study reported a decrease in
mI levels at 2.5 months of age as compared to age-matched wild-
type mice [131]. In the current and in our previous study [76], we
did not observe any differences in the levels of mI+Gly between
AbPP-PS1 and wild-type mice. In contrast, Chen and colleagues
observed significantly increased levels of mI in 3-, 5- and 8-month-
old AbPPswe-PS1dE9 mice, when pathology showed activation
and proliferation of astrocytes in the frontal cortex and hippo-
campus [138,139]. The discrepancy between the results found by
Chen et al. and our own findings are most likely due to differences
in methodology, e.g. the field strength of the MR system, the
acquisition parameters used, the exact position of the spectroscopic
volume of interest, the age of the animals, and the amount of
animals used.
Disturbances of several other metabolites have been found in
AD patients as well, although the reports are inconsistent. Some
studies identified elevated choline-containing compounds (tCho)
and creatine (Cre) in AD patients [140–142], whereas others did
not [125,143]. One possible explanation for the elevation of tCho
in AD is increased membrane turnover due to neurodegenerative
processes [144,145]. It has also been postulated that the elevation
of the tCho peak is the consequence of membrane phosphatidyl-
choline catabolism in order to provide free choline for the
chronically deficient acetylcholine production in AD [146,147]. In
agreement with our current findings, no differences were observed
between AbPP-PS1 and wild-type mice at any age tested in the
levels of tCho [76,133,138]. Dietary intake with the FC diet
significantly decreased the levels of tCho in AbPP-PS1 and wild-
type mice, suggesting diminished membrane turnover. Since the
FC diet provides precursors and cofactors in membrane synthesis
and maintenance that are not supplemented in the CO and DEU
diets, such as choline chloride and soy lecithin, these additional
nutrients might underlie the decreased levels of tCho. 1H MRS
studies to investigate the effect of the multi-nutrient FC diet on
brain metabolites in mild AD patients are currently ongoing.
Dietary intervention with the FC diet, but not with the DEU
diet, restored neurogenesis in AbPP-PS1 mice. Reduced hippo-
campal neurogenesis has been found previously in AbPP-PS1 mice
beyond 8 months of age [99,100,148] and in AD patients
[102,149,150]. In line with our results, previous studies have
shown that n3 lc-PUFAs [151,152], folic acid [153,154], and
vitamins and antioxidants [155,156] may promote neurogenesis.
Since the FC diet did not affect neurogenesis in wild-type mice,
our results could imply that this dietary intervention may
especially be beneficial when neurogenesis is severely compro-
mised. Dietary intervention with the FC diet might therefore be of
interest for several other neurodegenerative and neurological
disorders in which neurogenesis is impaired, such as Parkinson’s
disease and major depression.
Quantitative real-time PCR revealed increased IL-1b mRNA
levels in 12-month-old AbPP-PS1 mice as compared to age-
matched wild-type mice. In response to brain injury or infection,
IL-1b is both expressed by and targeted to many different cell
types within the brain, such as microglia, astrocytes, endothelial
cells, infiltrating leukocytes, neurons and oligodendrocytes [157–
159]. IL-1b has been implicated to be at or near the top of the
cytokine signaling cascade that initiates the neuroinflammatory
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changes seen in AD (reviewed in [160,161]). It has been suggested
that the initial burst of IL-1b production might actually have a
beneficial role in AD, by enhancing the microglial clearance of
amyloid plaques [161–163]. However, chronic elevation of IL-1b
is detrimental, since IL-1b is capable of propagating inflammatory
responses by increasing its own expression [161,162,164] and
inducing the expression of several other pro-inflammatory
cytokines, such as TNF-a and IL-6 [165], and chemokines, such
as MCP-1 [166,167]. Our results of increased IL-1b mRNA levels
in 12-month-old AbPP-PS1 mice, but no changes (yet) in the
mRNA levels of MCP-1, IL-6, TNF-a and CD36, might reflect
the initial burst of IL-1b production in response to brain injury or
toxic agents such as Ab.
Surprisingly, IL-1b mRNA levels were also elevated in both
AbPP-PS1 and wild-type mice in response to dietary intervention
with the DEU and FC diets. This seems contradictory to the anti-
inflammatory and immunosuppressive properties ascribed to n3 lc-
PUFAs, B vitamins and antioxidants [28,34,168]. However, IL-1b
signaling has also been associated with neuroprotective mecha-
nisms, including mediating the production of survival signals such
as nerve growth factor [169,170] and mediating re-myelination of
the central nervous system by stimulating oligodendrocytes
proliferation [159,171]. Interestingly, results from our own lab
indicate that both the DEU and FC diets prevent axonal
disconnection and myelin degradation, determined by diffusion
tensor MR imaging, in the 12-month-old AbPP-PS1 and wild-type
mice used in the current study (Zerbi et al., submitted data).
However, since prolonged elevation of IL-1b can initiate chronic
neuroinflammatory processes, the question remains whether the
effects of these multi-nutrient diets on IL-1b production are
ultimately beneficial or detrimental in the AbPP-PS1 mouse
model.
In conclusion, we showed that specific multi-nutrient diets can
ameliorate some AD-related pathologies in 11-12-month-old
AbPPswe-PS1dE9 mice. Although both diets were equally
effective in changing brain fatty acid profiles and cholesterol
metabolism, the diets differentially affected open field behavior,
hippocampal metabolite levels and neurogenesis, suggesting that
the effectiveness of specific nutrients may depend on the dietary
context in which they are provided. The multi-nutrient enriched
FC diet with DHA, EPA, UMP, phospholipids, choline, folic acid,
vitamins B6, B12, C, E and selenium (FortasynH Connect; FC diet)
was more effective than the DEU diet enriched with DHA, EPA
and UMP in counteracting neurodegenerative aspects of AD and
enhancing processes involved in neuronal maintenance and repair.
Intervention with the FC diet might therefore be of interest for
several other neurodegenerative and neurological disorders.
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